Indicated for the treatment of lymphoma in dogs.
- Kills cancer cells at the nuclear core
- Twice weekly at home oral administration
Conditionally approved by FDA pending full demonstration of effectiveness under application 141-526.
Related Documents
DP4200
Laverdia-CA1 2.5mg 50ct (Verdinexor) Tablets
/PennVet Catalog/TX - Product Categories/67 - Pharmaceuticals/105 - Oral Pharmaceuticals/12 - Chemotherapeutics/2 - Veterinary Labeled
/PennVet Catalog/TX - Manufacturers/DECHRA - Dechra
Product Detail Page